267 related articles for article (PubMed ID: 35331101)
41. Inhibition of UFM1 expression suppresses cancer progression and is linked to the dismal prognosis and immune infiltration in oral squamous cell carcinoma.
Ke D; Guo HH; Jiang N; Shi RS; Fan TY
Aging (Albany NY); 2023 Nov; 15(22):13059-13076. PubMed ID: 37980168
[TBL] [Abstract][Full Text] [Related]
42. Silencing of B7H4 Represses the Development of Oral Squamous Cell Carcinoma Through Promotion of M1 Macrophage Polarization.
Chi J; Liu Y; Yang L; Yang J
J Oral Maxillofac Surg; 2022 Aug; 80(8):1408-1423. PubMed ID: 35568099
[TBL] [Abstract][Full Text] [Related]
43. FBXW7 promotes autophagy and inhibits proliferation of oral squamous cell carcinoma.
Qiu B; Sun Y; Nie W; Yang Q; Guo X
Immun Inflamm Dis; 2023 May; 11(5):e845. PubMed ID: 37249289
[TBL] [Abstract][Full Text] [Related]
44. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
[TBL] [Abstract][Full Text] [Related]
45. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J
BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126
[TBL] [Abstract][Full Text] [Related]
46. HMGB1-activated tumor-associated macrophages promote migration and invasion via NF-κB/IL-6 signaling in oral squamous cell carcinoma.
Jiang M; Liu L; Huang W; Qi Y; Li Y; Li B
Int Immunopharmacol; 2024 Jan; 126():111200. PubMed ID: 37988913
[TBL] [Abstract][Full Text] [Related]
47. MCU That Is Transcriptionally Regulated by Nrf2 Augments Malignant Biological Behaviors in Oral Squamous Cell Carcinoma Cells.
Wu R; Zuo W; Xu X; Bi L; Zhang C; Chen H; Liu H
Biomed Res Int; 2021; 2021():6650791. PubMed ID: 34189138
[TBL] [Abstract][Full Text] [Related]
48. Dihydroartemisinin represses oral squamous cell carcinoma progression through downregulating mitochondrial calcium uniporter.
Zheng S; Wu R; Deng Y; Zhang Q
Bioengineered; 2022 Jan; 13(1):227-241. PubMed ID: 34847839
[TBL] [Abstract][Full Text] [Related]
49. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
[TBL] [Abstract][Full Text] [Related]
50. RCN1 deficiency inhibits oral squamous cell carcinoma progression and THP-1 macrophage M2 polarization.
Liu H; Guo H; Wu Y; Hu Q; Hu G; He H; Yin Y; Nan X; Lin G; Han J; Zhao R; Liu Y
Sci Rep; 2023 Dec; 13(1):21488. PubMed ID: 38057406
[TBL] [Abstract][Full Text] [Related]
51. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
Chen L; Zhu Q; Lu L; Liu Y
Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
[TBL] [Abstract][Full Text] [Related]
52. AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS.
Dawei H; Honggang D; Qian W
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):83-90. PubMed ID: 30454901
[TBL] [Abstract][Full Text] [Related]
53. Cyclosporine A Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in vitro.
Gao L; Dong J; Zhang N; Le Z; Ren W; Li S; Li F; Song J; Wang Q; Dou Z; Park SY; Zhi K
Anticancer Agents Med Chem; 2019; 19(2):248-255. PubMed ID: 30378503
[TBL] [Abstract][Full Text] [Related]
54. Downregulated microRNA-149-3p triggers malignant development and predicts worse prognosis in oral squamous cell carcinoma.
Shen Q; Xiong P; Yang D; Chen L
Arch Oral Biol; 2022 Feb; 134():105336. PubMed ID: 34891100
[TBL] [Abstract][Full Text] [Related]
55. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
Chen M; Zhang J
J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
[TBL] [Abstract][Full Text] [Related]
56. Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2.
Wang X; Zhang Y; Zhang S; Duan L
Arch Oral Biol; 2021 Oct; 130():105219. PubMed ID: 34364169
[TBL] [Abstract][Full Text] [Related]
57. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
Wang X; Chen Q
BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
[TBL] [Abstract][Full Text] [Related]
58. Lactic acid-induced M2-like macrophages facilitate tumor cell migration and invasion via the GPNMB/CD44 axis in oral squamous cell carcinoma.
Lin Y; Qi Y; Jiang M; Huang W; Li B
Int Immunopharmacol; 2023 Nov; 124(Pt B):110972. PubMed ID: 37806107
[TBL] [Abstract][Full Text] [Related]
59. The clinical significance, prognostic value and biological role of lncRNA LINC01793 in oral squamous cell carcinoma.
Yuan SJ; Li SY; Wang YH; Zhang HF; Hua Y; Wang T
Arch Oral Biol; 2021 May; 125():105105. PubMed ID: 33713982
[TBL] [Abstract][Full Text] [Related]
60. (S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition Through TGF-β/Smad4 Axis in Nasopharyngeal Carcinoma.
Chen Q; Wang Y; Li F; Cheng X; Xiao Y; Chen S; Xiao B; Tao Z
Anticancer Agents Med Chem; 2022; 22(6):1080-1090. PubMed ID: 34229595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]